$SGHT

Badawi Paul sold $155K of SGHT

Badawi Paul (President and CEO) sold 28,684 shares of Sight Sciences, Inc. (SGHT) at $5.42 ($0.16M total) on 2026-07-01 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Badawi Paul
Published Jul 6, 2026, 11:31 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 6, 2026, 11:36 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$SGHT
Neutral
high confidence
Mentioned
$SGHT
Relevance
3/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$SGHTNeutralLow
01

Why it matters

The disclosed sale is a sentiment datapoint; absent additional corporate developments, it is unlikely to drive a durable repricing.

02

Market read

Insider selling at $5.42/share is newly disclosed, but the 10b5-1 designation reduces interpretive weight.

03

What to watch

The filing does not disclose intent beyond the plan; traders should avoid inferring signal without corroborating news (guidance, trial, financing, or regulatory updates).

Relevance 3/10Novelty 4/10Timing: New Form 4 filed 2026-07-06 after-hours

Background

The article is a SEC Form 4 insider transaction disclosure for Sight Sciences, Inc.

Company-level read

Ticker impact

$SGHTNeutralHigh confidence
Context

Sight Sciences CEO Badawi Paul sold 28,684 shares on 2026-07-01 at $5.42/share under a pre-arranged 10b5-1 plan.

Expected impact

Likely limited near-term impact; any reaction should be muted given the stated 10b5-1 pre-arranged plan.

Evidence & confidence

Form 4 provides transaction mechanics (size, price, date) but no new company-specific operational or financial information.

Market effects

No clear sector read-through; this is an issuer-specific insider transaction.

None indicated.

None indicated.

Counterpoint

Because the sale is explicitly under a pre-arranged 10b5-1 plan, it may reflect scheduled liquidity rather than bearish expectations.

Key entities

  • Sight Sciences, Inc.

    Subject of the Form 4 insider transaction; CEO/President Badawi Paul sold shares.

  • Badawi Paul

    President and CEO; reported open-market sale under a pre-arranged 10b5-1 plan.

Related articles

$SGHTHigh

Sight Sciences, Inc. (SGHT): Results of Operations and Financial Condition

Sight Sciences, Inc. (SGHT) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 sght-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 Sight Sciences Reports Second Quarter 2026 Financial Results Raises Full-Year 2026 Revenue Guidance and Reduces Adjusted Operating Expense Guidance MENLO PARK, Calif., August 5, 2026 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (